Brought to you by 
SV Life Sciences seeds PanOptica
21 Aug 2009
Executive Summary
SV Life Sciences has seeded PanOptica with an undisclosed sum. The company was formed four months ago to in-license preclinical ophthalmic compounds for little or no cash up front, get them through proof-of-concept, then find partners for late-stage clinical development and marketing.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
SV Life Sciences seeds PanOptica
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice